School Located Influenza Vaccinations for Children: Community-Wide Dissemination

学校为儿童接种流感疫苗:社区范围内的传播

基本信息

  • 批准号:
    8708812
  • 负责人:
  • 金额:
    $ 47.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Annual influenza epidemics result in substantial mortality and morbidity among adults and children with more than $10 billion in direct medical costs. Although national guidelines recommend annual influenza vaccination of all school-aged children, less than half of these children are vaccinated. The major barrier is the short time window for vaccination: primary care practices are simply unable to vaccinate all of their pediatric patients within a few months. An alternative setting for child influenza vaccination is school-located influenza vaccinations (SLIV), yet <5% of children receive vaccine in schools. Three barriers impede SLIV: an ineffective paper-based parent consent system, ineffective parent reminders, and lack of experience with SLIV among adolescents. The goal of this project is to address these 3 barriers and to optimize influenza vaccination rates via SLIV. We will adapt two dissemination/implementation conceptual models (the Chronic Care Model and RE- AIM). We will work closely with schools, primary care practices, and local and state public health leaders, and with two national partners - CDC's National Center for Immunization and Respiratory Diseases (NCIRD) and the National Association of School Nurses (NASN). We propose a technical aim, a scientific aim, and a dissemination aim. The technical aim (Aim 1, Yr 1) is to develop, pilot, and evaluate a web-based consent and parent reminder system, using an innovative web-based informatics system. We will perform formative studies of parents, school staff, and providers, to create a useful system. The scientific aim (Aim 2, Yrs 2-4) is to perform effectiveness testing of SLIV, using web-based consent + reminders. We will randomize schools to SLIV vs. control in 3 successive annual RCTs, with increasing number of schools, and measure vaccination rates, school absences, and SLIV processes and costs. In Yr 2 we will include 5 schools districts (all elementary; 26 study, 28 control schools, n=25,078). In Yr 3 we will expand to 8 school districts and also middle/high schools (n=59,556 children); in Year 4 to 12 districts (n=79,713 children). The dissemination aim (Aim 3, Yrs 4-5) is to spread SLIV throughout Monroe County and diffuse SLIV best practices and technological innovations nationally. We will offer SLIV to all county schools (182 schools, n=112,034), and work with national partners to disseminate the consent/reminder system and a training program for SLIV across the US. This project addresses AHRQ priority area Prevention/Care Management, includes a focus on priority populations (adolescents, urban), and is a major redesign of primary care.
描述(由申请人提供):每年的流感流行导致成人和儿童的大量死亡和发病,直接医疗费用超过100亿美元。尽管国家指南建议所有学龄儿童每年接种流感疫苗,但这些儿童中只有不到一半接种了疫苗。主要的障碍是接种疫苗的时间窗口很短:初级保健实践根本无法在几个月内为所有儿科患者接种疫苗。儿童流感疫苗接种的另一种选择是学校流感疫苗接种(SLIV),但<5%的儿童在学校接种疫苗。三个障碍阻碍SLIV:无效的纸质家长同意系统,无效的家长提醒,以及缺乏青少年SLIV的经验。本项目的目标是解决这3个障碍,并通过SLIV优化流感疫苗接种率。我们将采用两种传播/实施概念模型(慢性病护理模型和RE-AIM)。我们将与学校,初级保健实践,地方和州公共卫生领导人以及两个国家合作伙伴- CDC的国家免疫和呼吸系统疾病中心(NCIRD)和全国学校护士协会(NASN)密切合作。我们提出了一个技术目标、一个科学目标和一个传播目标。技术目标(目标1,第1年)是使用创新的基于网络的信息系统,开发,试点和评估基于网络的同意和家长提醒系统。我们将对家长、学校工作人员和供应商进行形成性研究,以创建一个有用的系统。科学目的(目的2,第2-4年)是使用基于网络的知情同意书+提醒进行SLIV的有效性测试。我们将在连续3个年度随机对照试验中随机选择学校进行SLIV与对照,并增加学校数量,并测量疫苗接种率,学校缺勤率以及SLIV过程和成本。在第二年,我们将包括5个学区(所有小学; 26所研究学校,28所对照学校,n= 25,078)。在第三年,我们将扩大到8个学区和初中/高中(n= 59 556名儿童);在第四年,扩大到12个学区(n= 79 713名儿童)。传播目标(目标3,第4-5年)是在整个门罗县传播SLIV,并在全国范围内传播SLIV最佳实践和技术创新。我们将向所有县级学校(182所学校,n= 112,034)提供SLIV,并与国家合作伙伴合作,在美国各地传播同意/提醒系统和SLIV培训计划。该项目涉及AHRQ优先领域预防/护理管理,包括重点关注重点人群(青少年、城市),是对初级保健的重大重新设计。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER G SZILAGYI其他文献

PETER G SZILAGYI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER G SZILAGYI', 18)}}的其他基金

The STOP-HPV Scale-Up Study
STOP-HPV 扩大研究
  • 批准号:
    10564651
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
通过电子健康记录患者门户改善整个卫生系统的流感疫苗接种
  • 批准号:
    10319923
  • 财政年份:
    2018
  • 资助金额:
    $ 47.86万
  • 项目类别:
National Immunization Partnership with the APA (NIPA)
与 APA 的国家免疫合作伙伴关系 (NIPA)
  • 批准号:
    8916858
  • 财政年份:
    2014
  • 资助金额:
    $ 47.86万
  • 项目类别:
National Immunization Partnership with the APA (NIPA)
与 APA 的国家免疫合作伙伴关系 (NIPA)
  • 批准号:
    8931758
  • 财政年份:
    2014
  • 资助金额:
    $ 47.86万
  • 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
  • 批准号:
    8495004
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
  • 批准号:
    8266976
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
  • 批准号:
    8897991
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:
School Located Influenza Vaccinations for Children: Community-Wide Dissemination
学校为儿童接种流感疫苗:社区范围内的传播
  • 批准号:
    8551623
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
  • 批准号:
    8705921
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:
National Partnership for Adolescent Immunization
国家青少年免疫合作伙伴关系
  • 批准号:
    8529214
  • 财政年份:
    2012
  • 资助金额:
    $ 47.86万
  • 项目类别:

相似海外基金

Modelling to inform interventions during Highly Pathogenic Avian Influenza outbreaks in Great Britain
英国高致病性禽流感爆发期间的建模为干预措施提供信息
  • 批准号:
    BB/X016137/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Research Grant
ICF - Evaluate the potential of AstraZeneca's sialic acid tag technology for treating influenza viruses with Fc molecules
ICF - 评估阿斯利康唾液酸标签技术用 Fc 分子治疗流感病毒的潜力
  • 批准号:
    MR/Y503459/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Research Grant
ECOFLU : Understanding the ecology of Highly Pathogenic Avian Influenza in wild bird populations
ECOFLU:了解野生鸟类中高致病性禽流感的生态学
  • 批准号:
    NE/Y001591/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Research Grant
OSIB: Metabolic cartography of influenza A virus infection and host-pathogen interaction in the natural and accidental host
OSIB:自然和意外宿主中甲型流感病毒感染和宿主-病原体相互作用的代谢制图
  • 批准号:
    2318557
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Standard Grant
Syudy on highly pathogenic avian influenza infection in innate immunity
Syudy 论高致病性禽流感感染的先天免疫
  • 批准号:
    23H02364
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
H5N1 influenza virulence; interference in RIG-I detection in different hosts
H5N1流感毒力;
  • 批准号:
    494285
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Operating Grants
Regulation of RIG-I mediated antiviral response upon influenza A virus infection
RIG-I介导的甲型流感病毒感染抗病毒反应的调节
  • 批准号:
    494286
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Operating Grants
Flu:Trailmap "Transmission and risk of avian influenza: learning more to advance preparedness"
流感:路线图“禽流感的传播和风险:了解更多信息以做好准备”
  • 批准号:
    BB/Y00700X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Research Grant
FLU:Trailmap: Transmission and risk of avian influenza: learning more to advance preparedness
FLU:路线图:禽流感的传播和风险:了解更多信息以做好准备
  • 批准号:
    BB/Y007271/1
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    Research Grant
Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses
针对所有季节性和大流行性流感病毒的鼻内速效疫苗
  • 批准号:
    10080057
  • 财政年份:
    2023
  • 资助金额:
    $ 47.86万
  • 项目类别:
    EU-Funded
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了